Please provide your email address to receive an email when new articles are posted on . The FDA has granted a prior approval supplement to Zydus Lifesciences Limited allowing the company to market its ...

PITTSBURGH The Food and Drug Administration has given final approval to Mylan for its generic version of a drug used to prevent organ rejection in transplant patients. Mylan announced Thursday the ...

Lupin Limited, global pharmaceutical company, announced the launch of mycophenolate mofetil tablets USP, 500 mg, after Lupin’s alliance partner Concord Biotech Limited (Concord) received an approval ...

PRINCETON, N.J. The generics arm of Novartis has introduced its version of a drug used to prevent rejection of transplanted organs. Sandoz announced Friday that it had launched mycophenolate mofetil ...